Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Completed · Phase 1

Conditions studied: Head and Neck Cancer, Precancerous Condition

In brief

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. PURPOSE: This randomized phase I trial is studying the side effects and best dose of photodynamic therapy in treating patients with premalignant or early stage head and neck tumors.

Key facts

Study ID

NCT00978081

Run by

Abramson Cancer Center at Penn Medicine

People needed

35

Starts

2009-01-01

Expected to finish

2016-11-01

Last updated by the study team

2019-04-23

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.